Navigation Links
Suits Commenced Against Maker of Prescription Cleansing Drug
Date:12/23/2009

GREENSBORO, N.C., Dec. 23 /PRNewswire/ -- Suits were commenced Dec. 23, 2009 in North Carolina for four users who allege kidney damage due to the use of OsmoPrep, a prescription drug used to cleanse the intestines in preparation for a colonoscopy. (Holshouser et al v. Salix Pharmaceuticals, Ltd. and Salix Pharmaceuticals. Inc.)

The actions are against two Morrisville, N.C., pharmaceutical companies, Salix Pharmaceuticals, Ltd., and Salix Pharmaceuticals, Inc. ( SLXP). The company, which specializes in marketing gastrointestinal drugs, began selling OsmoPrep in 2006. It had over $30 million in sales in 2008.

OsmoPrep contains two types of sodium phosphates, which work by drawing water in the bowels. A large number of pills are taken the day before and the day of the colonoscopy. Salix also sells a product, Visicol, with similar chemicals and has the same purpose.

In December 2008, after receiving a number of reports of kidney injury, the FDA required Salix to place a black box warning on the product, as to serious kidney damage occurring after use of OsmoPrep and also Visicol. A black box warning is the most strict type of warning that the FDA can force a drug supplier to use in its labeling.

Also as a condition for continuing to market OsmoPrep, the FDA required Salix to perform what is known as a REMS evaluation--Risk Evaluation and Mitigation Strategies. These are designed to determine which population is more at risk in using the product, such as older person, those who are dehydrated or have pre-existing kidney damage, and those concurrently on other drugs.

The liquid form of these oral phosphates had been used in Fleet Phospho-Soda, an over-the-counter product manufactured by C. B. Fleet in Virginia. Fleet withdrew this product from the market in December 2008 in response to a similar request from the FDA to enhance its warnings.

The four plaintiffs in this suit, which was filed in Burke County, N.C., sustained a variety of serious kidney injuries, including the need for dialysis. The medical name for the condition they have suffered is acute phosphate nephropathy.

The complaint alleged that Salix was aware of the risks of serious kidney damage at the time of first marketing OsmoPrep and up until the FDA forced the black box warning. Such information came from articles in the medical literature and individual case reports.

The suit was commenced by the Greensboro, N.C., firm of WardBlackLaw, with assistance of the firm of Rheingold, Valet, Rheingold, Shkolnik and McCartney LLP, of New York City. The Rheingold firm is also involved with the Fleet Phospho-Soda litigation which has been consolidated in Cleveland, OH.


    Contact: Paul D. Rheingold
    Rheingold, Valet, Rheingold, Shkolnik & McCartney LLP
    113 East 37th Street
    New York, NY 10016
    (212) 684-1880
    prheingold@rheingoldlaw.com

SOURCE Rheingold, Valet, Rheingold, Shkolnik & McCartney LLP


'/>"/>
SOURCE Rheingold, Valet, Rheingold, Shkolnik & McCartney LLP
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent
2. Arnold & Itkin Announces Lawsuits Over Defective Pain Pumps
3. Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
4. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
5. Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria
6. Molnlycke Drives Home the Fight Against Staph and Other MRSA Infections
7. Mayo Clinic Study Finds FDA Warning Against Anti-Nausea Drug Droperidol Unnecessary
8. Targeted Nanoparticles Offer Promise in the Battle Against Cancer
9. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
10. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
11. Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... SAN DIEGO , Jan. 18, 2017 /PRNewswire/ ... manufacturing solutions for cell and advanced therapies , ... the French biopharmaceutical company developing "tumor starvation" treatments ... unmet medical needs. Under the agreement, Invetech will ... products based on Erytech,s proprietary ERYCAPS technology platform, ...
(Date:1/18/2017)... After the recent election cycle, it ... cannabis both for medical and recreational purposes are shifting. The ... the use of cannabis, but the focus is coming from ... Research, the North American legal cannabis market posted $6.7 billion ... The research projects sales will grow at a compound annual ...
(Date:1/17/2017)... , Jan. 17, 2017 North America Insulin ... new report, "North America Insulin Delivery Market Outlook to ... Insulin Delivery market. The report provides value, in millions ... (USD) within market segments - Insulin Pens, Insulin Pumps, ... report also provides company shares and distribution shares data ...
Breaking Medicine Technology:
(Date:1/18/2017)... KS (PRWEB) , ... January 18, 2017 , ... ... firm offering asset protection and financial planning services to families and business owners ... charity event aimed at supporting children with developmental disabilities. , The Lakemary Center ...
(Date:1/18/2017)... ... January 18, 2017 , ... Catalent Pharma Solutions, the leading ... consumer health products, today announced that Mr. Michael Merges, Director of Strategic Growth, ... be held at the Mayflower Hotel, Washington DC, on Jan. 24 – 26, ...
(Date:1/18/2017)... Lebanon, NH (PRWEB) , ... January 18, 2017 ... ... the launch of the revolutionary Active Brake Technology (ABT), an innovative braking system ... stability. , Active Brake Technology addresses one of the biggest concerns of beginner ...
(Date:1/17/2017)... ... ... January is National Stalking Awareness Month (NSAM), now in its fourteenth year, when ... the crime of stalking, a very real danger to many in our community. We ... and other crimes. , “Stalking: know it. Name it. Stop it.”—so reads the theme for ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... point of difference. Eden Activewear is a stand-out company for several differences from ... online and only manufacture on demand, this is called 'Agile' manufacturing - ...
Breaking Medicine News(10 mins):